Assessment of intracellular mucin content in vivo

L Piccotti, BF Dickey, CM Evans - Mucins: Methods and Protocols, 2012 - Springer
L Piccotti, BF Dickey, CM Evans
Mucins: Methods and Protocols, 2012Springer
Airway mucus presents a first line of defense against inhaled materials. It also, however, is a
significant pathological contributor to chronic lung diseases, such as asthma, cystic fibrosis,
and chronic obstructive pulmonary disease. Thus, gaining a better understanding of the
mechanisms of mucus production and secretion is an important goal for improving
respiratory health. Mucins, the chief glycoprotein components of airway mucus, are very
large polymeric glycoproteins, and measuring their production and secretion in experimental …
Abstract
Airway mucus presents a first line of defense against inhaled materials. It also, however, is a significant pathological contributor to chronic lung diseases, such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease. Thus, gaining a better understanding of the mechanisms of mucus production and secretion is an important goal for improving respiratory health. Mucins, the chief glycoprotein components of airway mucus, are very large polymeric glycoproteins, and measuring their production and secretion in experimental animals presents significant technical challenges. Over the past several years, we have developed assays for accurately quantifying mucin production and secretion using histological and biochemical assays. These methods are described here.
Springer